Gangliosides as Therapeutic Targets for Neurodegenerative Diseases

Gangliosides as Therapeutic Targets for Neurodegenerative Diseases

Gangliosides, sialic acid-containing glycosphingolipids, are abundant in cell membranes and primarily involved in controlling cell signaling and cell communication. The altered ganglioside pattern has been demonstrated in several neurodegenerative diseases, characterized during early-onset or infanc...

Full description

Bibliographic Details
Main Authors:	Orhan Kerim Inci, Hande Basırlı, Melike Can, Selman Yanbul, Volkan Seyrantepe
Format:	Article
Language:	English
Published:	Hindawi Limited 2024-01-01
Series:	Journal of Lipids
Online Access:	http://dx.doi.org/10.1155/2024/4530255

Similar Items

Analysis of Brain Lipids in the Early-Onset Tay–Sachs Disease Mouse Model With the Combined Deficiency of β-Hexosaminidase A and Neuraminidase 3
by: Melike Can, et al.
Published: (2022-08-01)

Autophagic flux is impaired in the brain tissue of Tay-Sachs disease mouse model.
by: Tugce Sengul, et al.
Published: (2023-01-01)

Gangliosides and the Treatment of Neurodegenerative Diseases: A Long Italian Tradition
by: Maria Fazzari, et al.
Published: (2022-02-01)

GM2 ganglioside accumulation causes neuroinflammation and behavioral alterations in a mouse model of early onset Tay-Sachs disease
by: Seçil Akyıldız Demir, et al.
Published: (2020-09-01)

Potential roles of gangliosides in chemical-induced neurodegenerative diseases and mental health disorders
by: Yutaka Itokazu, et al.
Published: (2024-04-01)

Uncoupling Proteins as Therapeutic Targets for Neurodegenerative Diseases
by: Colin J. Barnstable, et al.
Published: (2022-05-01)

Gangliosides in the Brain: Physiology, Pathophysiology and Therapeutic Applications
by: Simonetta Sipione, et al.
Published: (2020-10-01)

Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets
by: Chao Gao, et al.
Published: (2023-09-01)

TRP channels: Role in neurodegenerative diseases and therapeutic targets
by: Mashoque Ahmad Rather, et al.
Published: (2023-06-01)

Orexins as Novel Therapeutic Targets in Inflammatory and Neurodegenerative Diseases
by: Alain Couvineau, et al.
Published: (2019-10-01)

TRP Channels as Emerging Therapeutic Targets for Neurodegenerative Diseases
by: Chansik Hong, et al.
Published: (2020-04-01)

244 Targeting gangliosides in pediatric cancer
by: Min Huang, et al.
Published: (2023-11-01)

Neuraminidase-1 contributes significantly to the degradation of neuronal B-series gangliosides but not to the bypass of the catabolic block in Tay–Sachs mouse models
by: Z.K. Timur, et al.
Published: (2015-09-01)

The gangliosides
by: Lars Svennerholm
Published: (1964-04-01)

Gangliosides in Podocyte Biology and Disease
by: Berkan Savas, et al.
Published: (2020-12-01)

Ganglioside Metabolism and Parkinson's Disease
by: John Forsayeth, et al.
Published: (2018-02-01)

Therapeutic potential to target sialylation and SIGLECs in neurodegenerative and psychiatric diseases
by: Jannis Wißfeld, et al.
Published: (2024-03-01)

Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases
by: Giulia Gentile, et al.
Published: (2022-05-01)

Will Sirtuins Be Promising Therapeutic Targets for TBI and Associated Neurodegenerative Diseases?
by: Qianjie Yang, et al.
Published: (2020-07-01)

Lipid rafts and human diseases: why we need to target gangliosides
by: Jacques Fantini
Published: (2023-09-01)

Anti-ganglioside antibodies and celiac disease
by: Alessandro Granito, et al.
Published: (2021-05-01)

Gangliosides and Neuroblastomas
by: Cara-Lynne Schengrund
Published: (2020-07-01)

Gangliosides in milk
by: Slavica Potočki, et al.
Published: (2016-07-01)

The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets
by: Alhamdu Adamu, et al.
Published: (2024-04-01)

Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside
by: Yuan-Yuan Ma, et al.
Published: (2024-02-01)

JNK3 as Therapeutic Target and Biomarker in Neurodegenerative and Neurodevelopmental Brain Diseases
by: Clara Alice Musi, et al.
Published: (2020-09-01)

Pharmacological Inhibition of Ferroptosis as a Therapeutic Target for Neurodegenerative Diseases and Strokes
by: Yumin Wang, et al.
Published: (2023-08-01)

The gut microbiota in neurodegenerative diseases: revisiting possible therapeutic targets for cannabidiol
by: Bruna Stefane Alves de Oliveira, et al.
Published: (2022-12-01)

Mitochondrial Quality Control Strategies: Potential Therapeutic Targets for Neurodegenerative Diseases?
by: Di Hu, et al.
Published: (2021-11-01)

Galectins—Potential Therapeutic Targets for Neurodegenerative Disorders
by: Sapana Chaudhary, et al.
Published: (2022-09-01)

Ganglioside and Non-ganglioside Mediated Host Responses to the Mouse Polyomavirus.
by: John You, et al.
Published: (2015-10-01)

Ganglioside-magnetosome complex formation enhances uptake of gangliosides by cells
by: Guan F, et al.
Published: (2015-11-01)

Antioxidant Therapeutic Strategies in Neurodegenerative Diseases
by: Constanza Morén, et al.
Published: (2022-08-01)

Preferential Regulation of Γ‐Secretase‐Mediated Cleavage of APP by Ganglioside GM1 Reveals a Potential Therapeutic Target for Alzheimer's Disease
by: Xiaotong Wang, et al.
Published: (2023-11-01)

Role and therapeutic targets of P2X7 receptors in neurodegenerative diseases
by: Huiyong Zheng, et al.
Published: (2024-02-01)

Potential of Naturally Derived Alkaloids as Multi-Targeted Therapeutic Agents for Neurodegenerative Diseases
by: Yew Rong Kong, et al.
Published: (2021-01-01)

Neurodegenerative and Neurodevelopmental Diseases and the Gut-Brain Axis: The Potential of Therapeutic Targeting of the Microbiome
by: Brian Bicknell, et al.
Published: (2023-05-01)

Targeting Emerging Pathogenic Mechanisms by Natural Molecules as Potential Therapeutics for Neurodegenerative Diseases
by: Yan Dou, et al.
Published: (2022-10-01)

Editorial: Biomarkers and therapeutic targets in the pathogenesis of neurodegenerative diseases: Functions, implications, and perspectives
by: Junhui Wang
Published: (2023-03-01)

Targeting mitochondrial bioenergetics as a promising therapeutic strategy in metabolic and neurodegenerative diseases
by: Gurjit Kaur Bhatti, et al.
Published: (2022-10-01)